PHR Q4 2026

Q1 2027 Q4 2026 Q3 2026 Q2 2026

Earnings

Phreesia delivered a mixed fiscal fourth quarter, posting revenue of $127.07 million, up 15.8% year-over-year and edging past the $126.63 million consensus by 0.35%, while earnings per share of $0.02 fell sharply short of the $0.32 consensus estimate… Read more Phreesia delivered a mixed fiscal fourth quarter, posting revenue of $127.07 million, up 15.8% year-over-year and edging past the $126.63 million consensus by 0.35%, while earnings per share of $0.02 fell sharply short of the $0.32 consensus estimate, a miss of 93.73%. The headline revenue growth was powered in large part by the November 2025 acquisition of AccessOne, which drove payment solutions revenue up 45% year-over-year, alongside organic gains across subscription and network solutions. The company also swung to GAAP net income of $1.29 million from a net loss of $6.39 million a year ago, while adjusted EBITDA reached $29.42 million in the quarter. The brighter near-term picture, however, was clouded by a meaningful guidance cut; Phreesia lowered its fiscal 2027 revenue outlook to $510 million to $520 million from a prior range of $545 million to $559 million, citing reduced pharmaceutical manufacturer spending commitments in its network solutions segment. Wells Fargo maintained an Overweight rating on the stock but cut its price target to $15 from $25, reflecting the deceleration. Management kept its adjusted EBITDA outlook at $125 million to $135 million, expecting AI-driven efficiencies to absorb much of the revenue shortfall.